Royal Marsden Nhs Foundation Trust
Clinical trials sponsored by Royal Marsden Nhs Foundation Trust, explained in plain language.
-
Early trial halted after testing new cancer drug combo
Disease control TerminatedThis early-stage study aimed to find a safe dose for combining a new immunotherapy drug (pembrolizumab) with standard chemotherapy and radiation for patients with advanced head and neck cancer. It focused on measuring side effects, especially skin and mouth reactions, in a small …
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Apr 02, 2026 02:12 UTC
-
Early trial halted after testing Radiation-Immunotherapy combo for tough lung cancers
Disease control TerminatedThis early-stage trial aimed to test the safety of combining a type of targeted, high-dose radiation (lung SBRT) with an immunotherapy drug (pembrolizumab) for patients with advanced non-small cell lung cancer that had worsened after standard treatments. The study planned to find…
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Terminated trial sought new hope for tough cancer
Disease control TerminatedThis early-stage study tested whether combining a targeted, high-dose radiation (SBRT) with an immunotherapy drug (pembrolizumab) was safe and effective for patients with advanced, inoperable pleural mesothelioma whose cancer had progressed after initial chemotherapy. The trial w…
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC